Arrowhead Pharmaceuticals (Germany) Top Insiders
HDP1 Stock | EUR 21.10 0.45 2.18% |
Arrowhead Pharmaceuticals employs about 397 people. The company is managed by 10 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 39.7 employees per reported executive. Examination of Arrowhead Pharmaceuticals' management performance can provide insight into the company performance.
Christopher Anzalone CEO President CEO, Director |
Arrowhead |
Arrowhead Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.1285) % which means that it has lost $0.1285 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4043) %, meaning that it generated substantial loss on money invested by shareholders. Arrowhead Pharmaceuticals' management efficiency ratios could be used to measure how well Arrowhead Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Arrowhead Pharmaceuticals Workforce Comparison
Arrowhead Pharmaceuticals is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 3,148. Arrowhead Pharmaceuticals retains roughly 397 in number of employees claiming about 13% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.57. Arrowhead Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Arrowhead Pharmaceuticals Price Series Summation is a cross summation of Arrowhead Pharmaceuticals price series and its benchmark/peer.
Arrowhead Pharmaceuticals Notable Stakeholders
An Arrowhead Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Arrowhead Pharmaceuticals often face trade-offs trying to please all of them. Arrowhead Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Arrowhead Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Christopher Anzalone | President CEO, Director | Profile | |
Tracie Oliver | Chief Officer | Profile | |
Kenneth Myszkowski | Chief Officer | Profile | |
Javier MD | Chief Officer | Profile | |
PharmD JD | COO Counsel | Profile | |
Howard Lovy | Director Communications | Profile | |
Vincent CFA | Head VP | Profile | |
Mark Davis | Founder Calando | Profile | |
MBA MD | VP Medicine | Profile | |
Mark Seefeld | Head VP | Profile |
About Arrowhead Pharmaceuticals Management Performance
The success or failure of an entity such as Arrowhead Pharmaceuticals often depends on how effective the management is. Arrowhead Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Arrowhead management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Arrowhead management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. ARROWHEAD PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 116 people.
Arrowhead Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Arrowhead Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Arrowhead Pharmaceuticals within its industry.Arrowhead Pharmaceuticals Manpower Efficiency
Return on Arrowhead Pharmaceuticals Manpower
Revenue Per Employee | 612.7K | |
Revenue Per Executive | 24.3M | |
Net Loss Per Employee | 443.5K | |
Net Loss Per Executive | 17.6M |
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |